The Valley Desk

Clinical trial reportJournal of medicinal chemistryPublished

Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer Immunotherapy

12 of 44 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Clinical trial report
Venue
Journal of medicinal chemistry
Published
Subject terms
CHO Cells; Animals; Dogs; Macaca mulatta; Humans; Cricetulus; Mice; Rats; Rats, Wistar; Neoplasms; Triazoles; Quinazolines
PubMed ID
42084562
Added to directory
Source checked

Report a correction or request removal